Boston Capital Ventures

The firm's current investment strategy is not publicly documented. Historical data from the early 2000s through 2014 shows investments in early-stage technology and healthcare companies, primarily in the Northeastern US. The lack of a public website or recent fund filings makes its present focus unverifiable.

The identity of current managing partners is not publicly disclosed. Regulatory filings for previous funds listed individuals who have since moved to other firms or retired, and no updated leadership structure is available through public record, professional networks, or the firm's former website.

Based on public record, the firm's most recent known fund filing was for BCV IV in 2014. Since that time, no subsequent filings, press releases, or portfolio company announcements have been identified. This suggests the firm may be managing legacy assets rather than actively deploying new capital.

Total capital raised across its fund family is not publicly aggregated or disclosed. Individual fund sizes were not made public in regulatory filings, and no private placement memoranda or investor reports are available. Therefore, no reliable figure exists for its historical or current AUM.

Historical portfolio data indicates investments in enterprise software and medical device companies, though the outcomes of these investments are not consolidated in any public source. Some portfolio companies were acquired or went public, but no direct attribution to exit value for the firm's funds is verifiable.